Limin International Group Co. Ltd. Biopharmaceutical Division is a fast-growing unit joined by returned oversea biological and pharmaceutical scientists.

The Biopharmaceutical Division is mainly engaged in research, development, production and sales of bioactive proteins and clinical diagnostic reagents. Besides, it also provides biotechnological service such as protein expression (Escherichia coli, yeast, insect cell andmammalian cell systems), protein purification, microbial fermentation, protein interaction (yeast two-hybridization, CoIP, GST pulldown), Real-time quantitative PCR, ELISA, Western Blotting and so on.

The Biopharmaceutical Division has a high-quality research team composed of returned oversea biological and pharmaceutical scientists with over 20 years' experiences in R&D and production. And the Division has a close partnership with many research institutes in the United States.

The company is currently focusing on the R&D of many bioactive proteins and clinical diagnostic reagents which have very promising market prospects. We are one of the rare companies which both owns upstream core raw material technology and biotechnology platform. And we are dedicated to applying the R&D results of biological chemistry, cell biology, molecular biology, immunology and other fields to clinical use.